Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 2, 2010, Pages 125-132

  Yu, Y M ^a   Lin, H C ^b  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Curcumin; Human aortic smooth muscle cells migration; Matrix metalloproteinase 9; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CURCUMIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; RELA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE TRANSPORT; AORTA; ARTICLE; CELL CULTURE; CELL MOTION; CELL SURVIVAL; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTA; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B P50 SUBUNIT; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

CURCUMA LONGA;

EID: 75349110026     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.03.001     Document Type: Article

References (30)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Sasaguri Y., Murahashi N., Sugama K., Kato S., Hiraoka K., Satoh T., et al. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest 71 (1994) 261-269
3. Woessner Jr. J.F. Matrix metalloproteinasses and their inhibitors in connective tissue remodeling. FASEB J 5 (1991) 2145-2154
4. Birkedal-Hansen H., Moore W., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4 (1993) 197-250
5. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.G., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J 315 (1996) 335-342
6. Kutuk O., and Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 9 (2003) 549-557
7. Martin R., Hoeth M., Hofer-Warbinek R., and Schmid J.A. The transcription factor NF-κB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20 (2000) 83-88
8. Baeuerle P.A. The inducible transcription activator NFκB: regulation by distinct protein subunits. Biochim Biophys Acta 1072 (1991) 63-80
9. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50 (2001) 556-565
10. Cikrikci S., Mozioglu E., and Yilmaz H. Biological activity of curcuminoids isolated from Curcuma longa. Rec Nat Prod 2 (2008) 19-24
11. Aggarwal B.B., and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71 (2006) 1397-1421
12. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 78 (2006) 2081-2087
13. Yamaguchi T., Takamura H., Matoba T., and Terao J. HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-dipheny-2-picrylhydrazyl. Biosci Biotechnol Biochem 62 (1998) 1201-1204
14. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Miller A.A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84 (1993) 407-412
15. Mackness M.I., and Durringtom P.N. Lipoprotein separation & analysis for clinical studies. In: Converse C.A., and Skinner E.R. (Eds). Lipoprotein analysis: a practical approach (1992), IRL Press, Oxford 1-42
16. Chen Y.H., Lin S.J., Chen J.W., Ku H.H., and Chen Y.L. Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 135 (2002) 37-47
17. Demeule M., Brossard M., Page M., Gingras D., and Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 1478 (2000) 51-60
18. Bedoui J., Oak M.H., Anglard P., and Schini-Kerth V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc Res 67 (2005) 317-325
19. Kim Y.M., Kim K.E., Koh G.Y., Ho Y.S., and Lee K.J. Hydrogen peroxide produced by Angiopoietin-1 mediates angiogenesis. Cancer Res 66 (2006) 6167-6174
20. Strimpakos A.S., and Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10 (2008) 511-546
21. Ahsan H., Parveen N., Khan N.U., and Hadi S.M. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 121 (1999) 161-175
22. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21 (2001) 2895-2900
23. Baeuerle P.A., and Baltimore D. IκB: a specific inhibitor of the NFκB transcription factor. Science 242 (1988) 540-546
24. Muller J.M., Rupec R.A., and Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 11 (1997) 301-312
25. Sato H., and Seiki M. Regulatory mechanism of 92-kDa Type-IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 (1993) 395-405
26. Fini M.E., Bartlett J.D., and Matsubara M. The rabbit gene for 92-kDa matrix metalloproteinase: role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 269 (1994) 28620-28628
27. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50 (2001) 556-565
28. Kim C.H., and Moon S.K. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells. Arch Biochem Biophys 435 (2005) 264-272
29. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., and Lee Y.C. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cellcycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 301 (2003) 1069-1078
30. Yu Y.M., Lin H.C., and Chang W.C. Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br J Nutr 100 (2008) 731-738